Skip to content
BOLUS

Signal from the log

General Medicine

120 M$ · Series B · United States

General Medicine tient aux États-Unis une boutique de soins en ligne où l'on compare et achète médicaments, analyses, téléconsultations et consultations de spécialistes, avec le prix affiché avec et sans assurance. Levée de série B menée par Andreessen Horowitz, avec Eli Lilly au capital.

Verified

Announced on , logged by the watch of 6 October 2026.

Operation
Funding round
Announced amount
120 M$
Stage
Series B
Country
United States

What the log says

Editorial note, in French

Communiqué ouvert, montant relu et fonds nommés.

The investors

Led by Andreessen Horowitz , with Matrix , VXI Capital , Eli Lilly and Company , Mercy Health , BoxGroup

Provenance
Logged on 6 October 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Verified The press release was opened: amount double checked, funds named. The article remains to be written.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.

One address, nothing else.

One letter a week, on Fridays: the week's funding rounds, the funds named, the amounts double checked. The list is never sold, one click to unsubscribe. The letter is written in French.

You are, if you care to say

Email confirmation before any subscription. The list is never sold. What Bolus knows about you is written on the privacy page (in French).